CN111888523A - 一种用于改善肌肤的聚乳酸凝胶的制备方法 - Google Patents
一种用于改善肌肤的聚乳酸凝胶的制备方法 Download PDFInfo
- Publication number
- CN111888523A CN111888523A CN202010935973.XA CN202010935973A CN111888523A CN 111888523 A CN111888523 A CN 111888523A CN 202010935973 A CN202010935973 A CN 202010935973A CN 111888523 A CN111888523 A CN 111888523A
- Authority
- CN
- China
- Prior art keywords
- polylactic acid
- improving skin
- lactide
- reactor
- acid gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000747 poly(lactic acid) Polymers 0.000 title claims abstract description 56
- 239000004626 polylactic acid Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000011049 filling Methods 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 239000007787 solid Substances 0.000 claims abstract description 24
- 239000006185 dispersion Substances 0.000 claims abstract description 21
- 238000001035 drying Methods 0.000 claims abstract description 21
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 16
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 24
- 230000001681 protective effect Effects 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 15
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000012535 impurity Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000004698 Polyethylene Substances 0.000 claims description 11
- 229920001400 block copolymer Polymers 0.000 claims description 11
- 238000012662 bulk polymerization Methods 0.000 claims description 11
- -1 polyethylene Polymers 0.000 claims description 11
- 229920000573 polyethylene Polymers 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000012065 filter cake Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000007789 sealing Methods 0.000 claims description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- 229940109239 creatinine Drugs 0.000 claims description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- MMGJNINGVUMRFI-UHFFFAOYSA-N 15686-38-1 Chemical compound C1CC2(C3=C(C4=CC=CC=C4N3)C3)CCCCC2C3N1CC1CC1 MMGJNINGVUMRFI-UHFFFAOYSA-N 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 claims description 3
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 3
- 229960001701 chloroform Drugs 0.000 claims description 3
- 229960004194 lidocaine Drugs 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 6
- 230000003796 beauty Effects 0.000 abstract description 4
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 29
- 239000000463 material Substances 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 238000000926 separation method Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 206010054107 Nodule Diseases 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229920000359 diblock copolymer Polymers 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000007281 self degradation Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010935973.XA CN111888523A (zh) | 2020-09-08 | 2020-09-08 | 一种用于改善肌肤的聚乳酸凝胶的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010935973.XA CN111888523A (zh) | 2020-09-08 | 2020-09-08 | 一种用于改善肌肤的聚乳酸凝胶的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111888523A true CN111888523A (zh) | 2020-11-06 |
Family
ID=73226060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010935973.XA Pending CN111888523A (zh) | 2020-09-08 | 2020-09-08 | 一种用于改善肌肤的聚乳酸凝胶的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111888523A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112057673A (zh) * | 2020-09-08 | 2020-12-11 | 尹振宇 | 一种聚左旋乳酸组织填充剂的制备方法 |
CN113456888A (zh) * | 2021-08-04 | 2021-10-01 | 上海曜爱生物科技有限公司 | 一种左旋聚乳酸微球的制备方法 |
CN115531608A (zh) * | 2022-10-28 | 2022-12-30 | 广州远想医学生物技术有限公司 | 一种全水溶软组织填充剂及其制备方法 |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2555001A (en) * | 1999-12-22 | 2001-07-03 | Samyang Biopharmaceuticals Corporation | Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
WO2002049573A2 (en) * | 2000-12-18 | 2002-06-27 | Wockhardt Limited | Novel in-situ forming controlled release microcarrier delivery system |
KR20050064075A (ko) * | 2003-12-23 | 2005-06-29 | 주식회사 삼양사 | 이트라코나졸을 유효성분으로 하는 약학적 조성물 |
CN101007868A (zh) * | 2007-01-25 | 2007-08-01 | 复旦大学 | 一种生物降解性纳米胶束控释制剂的制备方法 |
CN101283966A (zh) * | 2008-06-05 | 2008-10-15 | 复旦大学 | 一种生物降解性水凝胶控释制剂及其制备方法和应用 |
CN101531756A (zh) * | 2009-04-16 | 2009-09-16 | 山东大学 | 一种水溶性聚乙二醇/聚乳酸多嵌段聚碳酸酯的制备方法 |
CN101891946A (zh) * | 2010-07-17 | 2010-11-24 | 厦门大学 | 一种具有dn-l结构的增强生物水凝胶及其制备方法 |
CN102344559A (zh) * | 2011-07-16 | 2012-02-08 | 西北大学 | 一种可注射温敏水凝胶及其制备方法 |
CN102702535A (zh) * | 2012-07-02 | 2012-10-03 | 南京大学 | 肌酐催化合成聚乳酸—聚乙二醇嵌段共聚物的工艺方法 |
CN103611195A (zh) * | 2013-11-21 | 2014-03-05 | 无锡中科光远生物材料有限公司 | 一种自粘止血防粘连纤维体 |
CN103980466A (zh) * | 2014-04-28 | 2014-08-13 | 苏州岸谷纳米材料科技有限公司 | 一种生物降解聚乳酸-聚乙二醇嵌段共聚物的制备方法 |
CN104559212A (zh) * | 2015-01-06 | 2015-04-29 | 山东理工大学 | 一种聚乳酸乙醇酸与聚乙二醇改进聚肽膜亲水性与柔顺性的方法 |
CN104645356A (zh) * | 2015-01-30 | 2015-05-27 | 复旦大学 | 一类x射线显影的热致水凝胶及其制备方法 |
CN104761710A (zh) * | 2014-02-14 | 2015-07-08 | 苏州海特比奥生物技术有限公司 | 一种聚乙二醇单甲醚-聚乳酸嵌段共聚物及其制备方法 |
KR101547611B1 (ko) * | 2015-02-13 | 2015-08-27 | (주)바이오제닉스 | 카테킨을 이용한 안정화된 레티놀 에멀젼 제조방법 |
CN104961886A (zh) * | 2015-04-30 | 2015-10-07 | 山西康宝生物制品股份有限公司 | 一种新型纳米胶束药用材料的制备方法 |
CN105749359A (zh) * | 2016-04-26 | 2016-07-13 | 山东省药学科学院 | 一种注射用皮肤填充剂及其制备方法和用途 |
CN107090079A (zh) * | 2017-05-26 | 2017-08-25 | 南京大学 | 一种聚乳酸‑聚乙二醇单甲醚双嵌段共聚物及其制备方法 |
WO2017155267A1 (ko) * | 2016-03-07 | 2017-09-14 | 성균관대학교산학협력단 | 자가 조립 나노입자 방출형 용해성 마이크로니들 구조체 및 그 제조방법 |
CN110804194A (zh) * | 2019-12-04 | 2020-02-18 | 黄春美 | 一种可降解型改性聚乳酸-聚乙二醇水凝胶及其制法 |
-
2020
- 2020-09-08 CN CN202010935973.XA patent/CN111888523A/zh active Pending
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2555001A (en) * | 1999-12-22 | 2001-07-03 | Samyang Biopharmaceuticals Corporation | Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
WO2002049573A2 (en) * | 2000-12-18 | 2002-06-27 | Wockhardt Limited | Novel in-situ forming controlled release microcarrier delivery system |
KR20050064075A (ko) * | 2003-12-23 | 2005-06-29 | 주식회사 삼양사 | 이트라코나졸을 유효성분으로 하는 약학적 조성물 |
CN101007868A (zh) * | 2007-01-25 | 2007-08-01 | 复旦大学 | 一种生物降解性纳米胶束控释制剂的制备方法 |
CN101283966A (zh) * | 2008-06-05 | 2008-10-15 | 复旦大学 | 一种生物降解性水凝胶控释制剂及其制备方法和应用 |
CN101531756A (zh) * | 2009-04-16 | 2009-09-16 | 山东大学 | 一种水溶性聚乙二醇/聚乳酸多嵌段聚碳酸酯的制备方法 |
CN101891946A (zh) * | 2010-07-17 | 2010-11-24 | 厦门大学 | 一种具有dn-l结构的增强生物水凝胶及其制备方法 |
CN102344559A (zh) * | 2011-07-16 | 2012-02-08 | 西北大学 | 一种可注射温敏水凝胶及其制备方法 |
CN102702535A (zh) * | 2012-07-02 | 2012-10-03 | 南京大学 | 肌酐催化合成聚乳酸—聚乙二醇嵌段共聚物的工艺方法 |
CN103611195A (zh) * | 2013-11-21 | 2014-03-05 | 无锡中科光远生物材料有限公司 | 一种自粘止血防粘连纤维体 |
CN104761710A (zh) * | 2014-02-14 | 2015-07-08 | 苏州海特比奥生物技术有限公司 | 一种聚乙二醇单甲醚-聚乳酸嵌段共聚物及其制备方法 |
CN103980466A (zh) * | 2014-04-28 | 2014-08-13 | 苏州岸谷纳米材料科技有限公司 | 一种生物降解聚乳酸-聚乙二醇嵌段共聚物的制备方法 |
CN104559212A (zh) * | 2015-01-06 | 2015-04-29 | 山东理工大学 | 一种聚乳酸乙醇酸与聚乙二醇改进聚肽膜亲水性与柔顺性的方法 |
CN104645356A (zh) * | 2015-01-30 | 2015-05-27 | 复旦大学 | 一类x射线显影的热致水凝胶及其制备方法 |
KR101547611B1 (ko) * | 2015-02-13 | 2015-08-27 | (주)바이오제닉스 | 카테킨을 이용한 안정화된 레티놀 에멀젼 제조방법 |
CN104961886A (zh) * | 2015-04-30 | 2015-10-07 | 山西康宝生物制品股份有限公司 | 一种新型纳米胶束药用材料的制备方法 |
WO2017155267A1 (ko) * | 2016-03-07 | 2017-09-14 | 성균관대학교산학협력단 | 자가 조립 나노입자 방출형 용해성 마이크로니들 구조체 및 그 제조방법 |
CN105749359A (zh) * | 2016-04-26 | 2016-07-13 | 山东省药学科学院 | 一种注射用皮肤填充剂及其制备方法和用途 |
CN107090079A (zh) * | 2017-05-26 | 2017-08-25 | 南京大学 | 一种聚乳酸‑聚乙二醇单甲醚双嵌段共聚物及其制备方法 |
CN110804194A (zh) * | 2019-12-04 | 2020-02-18 | 黄春美 | 一种可降解型改性聚乳酸-聚乙二醇水凝胶及其制法 |
Non-Patent Citations (2)
Title |
---|
张彦: "新型聚乳酸—聚乙二醇水凝胶胸腺五肽药物缓释研究", 《中国优秀博硕士学位论文全文数据库(硕士)工程科技Ⅰ辑》 * |
薛巍,张渊明主编: "《生物医用水凝胶》", 31 December 2012, 暨南大学出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112057673A (zh) * | 2020-09-08 | 2020-12-11 | 尹振宇 | 一种聚左旋乳酸组织填充剂的制备方法 |
CN113456888A (zh) * | 2021-08-04 | 2021-10-01 | 上海曜爱生物科技有限公司 | 一种左旋聚乳酸微球的制备方法 |
CN115531608A (zh) * | 2022-10-28 | 2022-12-30 | 广州远想医学生物技术有限公司 | 一种全水溶软组织填充剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111888523A (zh) | 一种用于改善肌肤的聚乳酸凝胶的制备方法 | |
CN108310460B (zh) | 可注射高强度温敏性改性甲壳素基水凝胶及其制备方法和应用 | |
CN110522948B (zh) | 可注射水凝胶及其制备方法和应用 | |
CN107496974B (zh) | 一种基于葡聚糖和壳聚糖的双组份医用粘合剂及其制备方法 | |
CN107469135B (zh) | 一种心脏封合凝胶及其制备方法 | |
CN101628947B (zh) | 一种壳聚糖-聚乳酸接枝共聚物及其制备方法和应用 | |
CN113248732A (zh) | 可注射自适应天然水凝胶粘合剂的制备方法 | |
CN109575683B (zh) | 一种适用于3d生物打印的水凝胶墨水的制备方法 | |
CN114668897B (zh) | 一种抗菌、可粘附、可自愈合的水凝胶及其制备方法和应用 | |
CN113214503B (zh) | 一种氨基酸基聚氨酯超分子高黏性凝胶贴片的制备及应用 | |
CN107501577B (zh) | 一种可降解原位凝胶的制备方法 | |
CN113425890A (zh) | 一种仿生水凝胶组织粘合剂及其制备方法 | |
CN112587715A (zh) | 一种高黏结医用复合胶黏剂的制备方法 | |
CN113876741A (zh) | 湿态可粘附的口腔凝胶贴片的制备与应用 | |
CN113861451A (zh) | 一种生物医用组织粘合剂的制备方法 | |
WO2022170681A1 (zh) | 一种可降解的双组份水凝胶及其制备方法与应用 | |
CN110384822B (zh) | 眼用粘合封闭胶及其制备方法 | |
JP6561133B2 (ja) | 生体適合性組成物及びこの製造方法 | |
CN115429935B (zh) | 一种可注射性的交联硫酸软骨素水凝胶及其制备方法 | |
CN114891196B (zh) | 可注射凝胶聚羟基脂肪酸酯及其制备方法和用途 | |
CN113150323B (zh) | N-(2-羟丙基)甲基丙烯酰胺透明质酸水凝胶、制备方法及应用 | |
CN102631713B (zh) | 一种可降解的术后防粘连膜及其制备方法 | |
CN111053946B (zh) | 一种基于多糖和超支化多肽的双组分组织粘合剂及其制备方法 | |
CN113444232A (zh) | 一种可用于伤口敷料的可降解聚合物及其制备方法及伤口敷料 | |
CN104640904B (zh) | 生物分解性高分子化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210716 Address after: 130000 FAW Fourth Ring Xufa Building B1 and B2, about 500 meters east of the intersection of Xinggong Road and Haier Street in Kuancheng District, Changchun City, Jilin Province Applicant after: JINLIN HANGGAI TONGBO BIOTECHNOLOGY Co.,Ltd. Address before: 130000, 500m eastward at the intersection of Haier Avenue and Xinggong Road, Kuancheng District, Changchun City, Jilin Province Applicant before: Yin Zhenyu |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201106 |
|
RJ01 | Rejection of invention patent application after publication |